FTO and acute myeloid leukemia: Huang et al. (109) developed two promising FTO inhibitors, namely, FB23 and FB23-2, which can directly bind to FTO, selectively inhibit its m6A demethylase activity (particularly FB23-2), and thus play a role in AML.